GSK3B and Alzheimer disease: RAGE exacerbates the neuronal toxicity of Aβ and subsequently activates GSK-3β, which can lead to the cascade of pathologies associated with AD, whereas simultaneous inhibition of GSK-3β reverses the neuronal damage aggravated by Aβ [67].